MedTrace Logo

Carbetocin Compared To Oxytocin During Cesarean Delivery

NCT05758012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2023-03-07

No results posted yet for this study

Summary

As both oxytocin and carbetocin are used daily in obstetric units all over the world, the investigators find it compelling to investigate whether the hemodynamic and myocardial effects of oxytocin and carbetocin are comparable in healthy women during delivery and determine any potential harmful effects following the use of oxytocin or Carbetocin as uterotonic. Other endpoints relating to uterus tone, blood loss, blood pressure, heart rate, post-operative pain and side effects will also be assessed.

Conditions

  • Cesarean Delivery

Interventions

DRUG

oxytocin

Participants will be randomized to receive Oxytocin after delivery of the baby's head and shoulders

DRUG

Carbetocin

Participants will be randomized to receive Cabetocin after delivery of the baby's head and shoulders

Sponsors & Collaborators

  • Ministry of Health, Kuwait

    collaborator OTHER_GOV

  • Assiut University

    lead OTHER

Principal Investigators

  • Fatemah Qasem · Ministry of Health, Kuwait

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-11-01
Completion
2024-12-01
FDA Drug
Yes

Countries

  • Kuwait

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758012 on ClinicalTrials.gov